Literature DB >> 23455890

Tuberculosis complications after BCG treatment for urinary bladder cancer.

Albinas Naudžiūnas1, Rūta Juškaitė, Indrė Žiaugrytė, Alvydas Unikauskas, Eglė Varanauskienė, Edita Mašanauskienė.   

Abstract

Bacillus Calmette-Guérin (BCG) is an attenuated strain of Mycobacterium bovis that has been effectively used in the treatment of non-muscle invasive bladder carcinoma. The complications of this treatment are uncommon, and the causes of dissemination are still discussed. We report a case of disseminated tuberculosis in a 66-year-old smoking man without a history of pulmonary diseases, who underwent immunotherapy with BCG after the initial surgical treatment of bladder cancer. After the last BCG instillation, he developed a fever. The diagnosis of sepsis was not confirmed, and miliary pulmonary tuberculosis was suspected. The diagnosis was confirmed by clinical manifestation, computed tomography of the lungs, and histological examination.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23455890

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  3 in total

1.  Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment.

Authors:  Uyen To; Joyce Kim; David Chia
Journal:  Case Rep Med       Date:  2014-06-12

Review 2.  Understanding the early host immune response against Mycobacterium tuberculosis.

Authors:  Babban Jee
Journal:  Cent Eur J Immunol       Date:  2020       Impact factor: 2.085

3.  Disseminated Granulomatous Disease from Intravesical Instillation of Bacillus Calmette-Guerin.

Authors:  Sayed Ab Reshad Ghafouri; Alexander Brun; Rohit Bhalla; Craig Margulies; Kevin Skole
Journal:  Case Rep Oncol Med       Date:  2018-08-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.